SPIA
AVXL icon

Steward Partners Investment Advisory’s Anavex Life Sciences AVXL Stock Holding History

Steward Partners Investment Advisory’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,500
Closed -$4.61K – 4671
2026
Q1 		$4.61K Sell
1,500
-819
-35% -$3.55K ﹤0.01% 3825
2025
Q4 		$8.26K Buy
2,319
+500
+27% +$3.06K ﹤0.01% 3519
2025
Q3 		$16.2K Buy
+1,819
New +$18.4K ﹤0.01% 3180
2024
Q4 		– Sell
-250
Closed -$1.42K – 3979
2024
Q3 		$1.42K Hold
250
– – ﹤0.01% 3496
2024
Q2 		$1.05K Hold
250
– – ﹤0.01% 3385
2024
Q1 		$1.27K Hold
250
– – ﹤0.01% 3350
2023
Q4 		$2.33K Sell
250
-400
-62% -$2.75K ﹤0.01% 3174
2023
Q3 		$4.26K Sell
650
-5,200
-89% -$41.4K ﹤0.01% 2880
2023
Q2 		$47.6K Hold
5,850
– – ﹤0.01% 1908
2023
Q1 		$50.1K Hold
5,850
– – ﹤0.01% 1862
2022
Q4 		$54.2K Hold
5,850
– – ﹤0.01% 1805
2022
Q3 		$60K Hold
5,850
– – ﹤0.01% 1703
2022
Q2 		$59K Hold
5,850
– – ﹤0.01% 1721
2022
Q1 		$72K Hold
5,850
– – ﹤0.01% 1732
2021
Q4 		$101K Hold
5,850
– – ﹤0.01% 1598
2021
Q3 		$105K Buy
5,850
+650
+13% +$12.9K ﹤0.01% 1516
2021
Q2 		$119K Buy
5,200
+1,200
+30% +$17.8K ﹤0.01% 2006
2021
Q1 		$59.8K Buy
4,000
+3,000
+300% +$32.8K ﹤0.01% 1889
2020
Q4 		$5K Hold
1,000
– – ﹤0.01% 2500
2020
Q3 		$5K Sell
1,000
-1,000
-50% -$4.3K ﹤0.01% 2347
2020
Q2 		$10K Buy
2,000
+1,000
+100% +$3.78K ﹤0.01% 2027
2020
Q1 		$3K Buy
+1,000
New +$3.48K ﹤0.01% 2194
2018
Q1 		– Sell
-500
Closed -$1K – 2222
2017
Q4 		$1K Hold
500
– – ﹤0.01% 1763
2017
Q3 		$2K Buy
+500
New +$2.22K ﹤0.01% 1470

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Steward Partners Investment Advisory's AVXL Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 1,500 shares — an estimated $4.61K sold.

Steward Partners Investment Advisory first reported a position in AVXL in Q3 2017 and held it in 24 quarters. The position peaked at $119K in Q2 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Steward Partners Investment Advisory reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,500 Anavex Life Sciences shares in Q2 2026, an estimated $4.61K.
  • Steward Partners Investment Advisory first reported a position in Anavex Life Sciences in Q3 2017 and held it in 24 quarters.
  • Steward Partners Investment Advisory's Anavex Life Sciences position peaked at $119K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.